Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expiration
See the DrugPatentWatch profile for Tepezza
The U.S. launch date for Tepezza (teprotumumab-trgb) was February 3, 2020 [1]. It received Food and Drug Administration (FDA) approval on January 21, 2020 [2].
Other Questions About Tepezza :